VHCP Management as of March 31, 2013
Portfolio Holdings for VHCP Management
VHCP Management holds 15 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 24.9 | $33M | 1.8M | 18.28 | |
| Neurocrine Biosciences (NBIX) | 18.1 | $24M | 2.0M | 12.16 | |
| Keryx Biopharmaceuticals | 10.9 | $14M | 2.0M | 7.05 | |
| Tesaro | 10.9 | $14M | 657k | 21.96 | |
| Anacor Pharmaceuticals In | 7.9 | $10M | 1.6M | 6.46 | |
| GTx | 5.6 | $7.4M | 1.8M | 4.15 | |
| Hyperion Therapeutics | 5.0 | $6.6M | 255k | 25.82 | |
| Dyax | 4.4 | $5.8M | 1.3M | 4.36 | |
| Chelsea Therapeutics International | 3.9 | $5.1M | 2.5M | 2.04 | |
| Biodel | 2.7 | $3.6M | 1.3M | 2.84 | |
| Threshold Pharmaceuticals | 2.4 | $3.2M | 684k | 4.61 | |
| Alexza Pharmaceuticals | 1.7 | $2.2M | 500k | 4.42 | |
| Anthera Pharmaceuticals | 0.7 | $949k | 1.4M | 0.66 | |
| Amicus Therapeutics (FOLD) | 0.4 | $520k | 164k | 3.17 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $468k | 393k | 1.19 |
